Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma
1 other identifier
interventional
71
1 country
1
Brief Summary
This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 17, 2017
CompletedFirst Submitted
Initial submission to the registry
December 13, 2018
CompletedFirst Posted
Study publicly available on registry
December 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2022
CompletedOctober 23, 2023
October 1, 2023
5.3 years
December 13, 2018
October 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Sun Exposure Behaviors
A short questionnaire is administered during the clinic visit to assess sun exposure behaviors of melanoma patients. The data gathered from this questionnaire will help identify possible trends in sun exposure behaviors and provide a baseline dataset for future research,
Start of study, initial interaction with participants.
UV Exposure Assessment
Identify the difference between self-reported sun exposure behavior and actual UV exposure by having patients wear individual dosimeters
Start of study to end of study, up to 6 weeks
Visual Appearance Relationships: Melanoma, Questionnaire
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a sun exposure questionnaire
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Non-Melanoma , Questionnaire
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a sun exposure questionnaire
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Melanoma, Photography
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a UV photography
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Non-Melanoma, Photography
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a UV photography
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Melanoma, Casting
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a silicone casts
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Non-Melanoma, Casting
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a silicone casts
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Melanoma, SCINEXA
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in melanoma patients using a SCINEXA exam.
Start of study to end of study, up to 3 years
Visual Appearance Relationships: Non-Melanoma, SCINEXA
Determine the relationship between UV camera score, skin patch, sun exposure history, and phenotypic evaluation in non-melanoma patients using a SCINEXA exam.
Start of study to end of study, up to 3 years
Genetics Correlations
Determine whether UV exposure and camera scores correlates with UV signature (somatic) mutations and other tumor-related mutations in clinically benign nevi and primary melanomas using saliva samples, benign nevi, and primary melanomas. Next Generation Sequencing (NGS) will be used to obtain the genetic information from all samples.
Start of study to end of study, up to 3 years
Secondary Outcomes (10)
Self Reporting Behaviors
Start of study to end of study, up to 3 years
Behavioral Intervention and Immediate Follow Up
After wearing dosimetry for 3 weeks
Benign Nevi, DNA
Start of study to end of study, up to 3 years
Benign Nevi, Mutations
Start of study to end of study, up to 3 years
Benign Nevi, Exposure
Start of study to end of study, up to 3 years
- +5 more secondary outcomes
Study Arms (3)
UV Counseling
OTHEREvaluate the effectiveness of dosimetry feedback on sun exposure behaviors, attitudes, and awareness in patients diagnosed with melanoma.
Visual Analysis - UV Photo
EXPERIMENTALAssess the relationships between UV camera score, silicone mold of a skin patch, phenotypic evaluation and sun-exposure behaviors. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Biological Sample
EXPERIMENTALDetermine the relationship between measures of sun exposure and genomic characteristics of tumors in melanoma patients. Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Interventions
This is a sub-study that involves a behavioral intervention. Participants will wear a UV dosimetry for 3 weeks, return the device and receive feedback. After the feedback, they will re-wear the device for an additional 3 weeks.
Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Technically, this arm is a sub-study that does not involve an intervention. Patients are not receiving an intervention; they are simply providing data to the study team.
Eligibility Criteria
You may qualify if:
- \> or = 18 years of age
- Patient at the University of Colorado Anschutz Medical Campus Cutaneous Oncology Clinic or Dermatology Clinic OR attend the fundraising event of the Colorado Melanoma Foundation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil Box, PhD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2018
First Posted
December 21, 2018
Study Start
February 17, 2017
Primary Completion
June 17, 2022
Study Completion
June 17, 2022
Last Updated
October 23, 2023
Record last verified: 2023-10